BRIEF-Valeant Pharmaceuticals announces new licensing arrangement for Brodalumab in Europe By: Reuters: Company News July 01, 2016 at 02:09 AM EDT July 1 (Reuters) - Valeant Pharmaceuticals International Inc : Read More >> Related Stocks: Astrazeneca Plc ADR Valeant Pharmaceuticals International, Inc.